Edit |   |
---|---|
Antigenic Specificity | EGFR, Human (Cetuximab biosimilar) |
Clone | Cetuximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human EGFR Recombinant Antibody (Cetuximab). Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co. |
Immunogen | n/a |
Other Names | Anti-EGFR Recombinant Antibody, Research Grade Cetuximab, Anti-Human EGFR Recombinant Antibody(Cetuximab), Fab C225, IMC-225, Antibody Drug Analogues, Monoclonal Antibody, YR1089, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 205923-56-4 |
Catalog # | YR1089 |
Price | please inquire |
Order / More Info | EGFR, Human (Cetuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |